TUCSON, October 25, 2016 – The Critical Path Institute’s (C-Path) Critical Path to TB Drug Regimens (CPTR) initiative and the Global TB Programme of the World Health Organization (WHO) have partnered with researchers from the University of California, San Francisco (UCSF), to develop leading-edge quantitative analyses of data from the TB-Platform for Aggregation of Clinical TB Studies (TB-PACTS)database. This collaboration, called TB-ReFLECT, will extract from these analyses key lessons from the TB-PACTS platform, and then package such lessons as tools for future TB trial design.Continue reading
Category Archives: AZBio News
Announcing the 2016 AZBio Trailblazers
The 2016 AZBio Honorees are: Senator Nancy Barto, Senator Bob Worsley, Senator Kimberly Yee, Speaker Pro Tem Bob Robson, Representative Kate Brophy McGee, Representative Heather Carter, Representative Regina Cobb, DDS, Representative Randall Friese, MD, Representative Jay Lawrence, Representative Eric Meyer, MD Continue reading
EKN Duisburg Becomes 1st Device-Only Center to Reach 50 SynCardia Artificial Heart Implants
Recognized 50cc SynCardia TAH-t world leader, Evangelisches Krankenhaus Duisburg-Nord, celebrates another milestone.Continue reading
Castle Biosciences Announces Launch of New Eye Cancer Test to Measure Expression of PRAME Gene
PRAME expression, when combined with DecisionDx-UM test results, correlates with increased risk of metastasis in patients with uveal melanoma
Male mutations are driving evolution. How’s that working out?
The word mutation conjures many images in the popular mind, virtually all of them negative. Mutations in the human genome cause crippling birth abnormalities and are the source of innumerable genetic diseases, from hemophilia and sickle cell anemia to congenital heart defects and cancer.Continue reading
“Heart to Heart with Dr. Martha Gulati” video series launched
Leaders attend kickoff to spread the message of heart disease prevention, ask community to share the video – save a lifeContinue reading
BIO 2017 Call for Speakers and Sessions
BIO will bring together the most innovative thinkers in biotechnology next June at BIO 2017 in San Diego. This is your chance to submit provocative, cutting-edge topics that affect the global biotechnology industry, including: healthcare, intellectual property, environmental issues, and business development. Do you have insights into the latest biotech breakthrough?Continue reading
Time to Apply for RESI San Francisco 2017
If you are a scientist-entrepreneur or fundraising CEO starting to accumulate compelling proof-of-concept animal data or early stage clinical data, the RESI Innovation Challenge is for you.Continue reading
Time to Apply for the 2017 Flinn Foundation Bioscience Entrepreneurship Program
Applications are now being accepted for the 2017 Flinn Foundation Bioscience Entrepreneurship Program for early-stage bioscience firms. The deadline to apply is November 6, 2016.Continue reading